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1 ABSTRACT
2 Cell-material interactions and compatibility are important aspects of bioactive materials for 
3 bone tissue engineering. Phosphate glass fiber (PGF) is an attractive inorganic filler with fibrous 
4 structure and tunable composition, which has been widely investigated as a bioactive filler for 
5 bone repair applications. However, the interaction of osteoblasts with PGFs has not been widely 
6 investigated to elucidate the osteogenic mechanism of PGFs. In this study, different concentrations 
7 of short PGFs with interlaced oriented topography were co-cultured with MC3T3-E1 cells for 
8 different periods, and the synergistic effects of fiber topography and ionic product of PGFs on 
9 osteoblast responses including cell adhesion, spreading, proliferation and osteogenic 
10 differentiation were investigated. It was found that osteoblasts were more prone to adhere on 
11 PGFs through vinculin protein, leading to enhanced cell proliferation with polygonal cell shape 
12 and spreading cellular actin filaments. In addition, osteoblasts incubated on PGF meshes showed 
13 enhanced alkaline phosphatase (ALP) activity, extracellular matrix mineralization, and increased 
14 expression of osteogenesis-related marker genes, which could be attributed to the 
15 Wnt/β-catenin/Runx2 signaling pathway. This study elucidated the possible mechanism of PGF on 
16 triggering specific osteoblast behavior, which would be highly beneficial for designing PGF-based 
17 bone graft substitutes with excellent osteogenic functions.
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1 1. Introduction
2     Bone loss is one of the most important causes of skeletal disease such as congenital defects, 
3 oral and maxillofacial pathologies and osteoporosis leading to bone fractures1. Many studies focus 
4 on bone tissue engineering strategies for skeletal tissue regeneration. In bone tissue engineering, 
5 engineered scaffolds can provide specific microenvironment and architecture for cell adhesion, 
6 migration, proliferation and even bone formation by regulating osteogenic differentiation2. The 
7 stiffness, elasticity, topography, morphology and specific degradation products of the scaffold can 
8 regulate cell-cell, cell-ECM and cell-material interactions3. Scaffold architecture is reported to be 
9 critically important for bone regeneration as it could be made to mimic the native 3D environment 
10 for osteoblasts in order to promote cell adhesion and activation4, 5. In addition, bioactive 
11 constituents of the scaffold are also important characteristics of bone tissue engineering materials6. 
12 On the one hand, materials can provide bioactivity to interact with surrounding cells and tissues 
13 and avoid the host immune response7. On the other hand, biomaterial surfaces can present 
14 osteo-inductive factors such as calcium ions and growth factors to the local microenvironment in 
15 order to enhance bone formation7, 8. 
16 Phosphate-based glasses have gained increasing attention9, 10, because of their similar 
17 composition to the inorganic component of native bone, biocompatibility, bioactivity, and 
18 osteo-conductivity11, 12. It has been previously reported that biodegradable composites reinforced 
19 with phosphate glass fibers (PGFs) could promote the proliferation of preosteoblasts13. PGFs have 
20 also been shown to promote neuronal polarization and directional growth of axons in vitro and in 
21 vivo, potentially repairing peripheral nerve injury in vivo14-16. In addition, fibrous chitosan-glued 
22 phosphate glass fiber scaffolds were shown to be non-cytotoxic against bone marrow stromal 
23 cells17. Furthermore, nanocomposite polymer scaffolds using sacrificial phosphate glass fibers 
24 have shown support for the growth of human tenocytes cells18. It was also recently reported that 
25 PGFs can be deposited as coating on bulk metallic surfaces to enhance the proliferation and 
26 expression of osteogenic-related genes in MC3T3-E1 cells19. These attractive characteristics and 
27 higher bioactivity of PGFs suggest that they can be considered suitable building blocks for bone 
28 scaffolds and can function as an excellent tissue engineering material.
29 Osteogenic differentiation involves several key steps including cellular proliferation, 
30 extracellular matrix (ECM) synthesis, and ECM mineralization20. The corresponding signaling 
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1 systems related to osteogenesis and bone growth include Wnt signal pathway, transforming 
2 growth factor beta (TGF-β) signal pathway, mitogen-activated protein kinases (MAPK) signal 
3 pathway among others21. Transcription factors play an important role in regulating proliferation 
4 and differentiation of osteoblasts20. Runt-related transcriptional factor 2 (Runx2), an 
5 osteoblast-specific transcription factor, can combine with osteoblast specific cis element in the 
6 osteocalcin promoter22 and regulate the process of mesenchymal stem cell differentiation into 
7 osteoblasts by promoting the expression of osteoblast-specific genes, such as ALP, OCN, and 
8 ColI23. Studies have reported that overexpression of Runx2 could induce osteogenesis in vitro and 
9 in vivo, and also accelerate the healing of bone defects in the skulls of mice24. 
10 It has been reported that calcium ion induced Wnt signalling is essential for bone tissue 
11 formation25-27. Wnt/β-catenin is an important upstream signal transduction of Runx2 for regulating 
12 bone formation and bone metabolism diseases by influencing the expression of osteogenic specific 
13 genes28. During osteogenesis, Wnt signaling is activated, non-phosphorylated β-catenin in 
14 cytoplasm accumulates and translocates into the nucleus and then β-catenin binds with 
15 Groucho/TCF/LEF complex to induce gene transcription29. Inhibition of Wnt/β-catenin activation 
16 was found to reduce bone formation in mice30. 
17 Many studies have indicated that PGFs with their fibrous structure and tunable composition 
18 offer great potential for biomedical applications. Previous work by some of the authors reported 
19 that P50 PGFs was sufficient for muscle cell attachment and differentiation12. However, the 
20 interaction of osteoblasts with P50 PGFs and the mechanism of P50 PGFs on the function of 
21 osteoblasts are not fully understood. In this study, P50 PGFs were employed to investigate the 
22 influence of topography and degradation products on osteoblasts behavior, including cell 
23 spreading, adhesion, proliferation and differentiation. Moreover, the mechanism of PGFs on 
24 osteogenic marker expression and osteogenesis ability has also been investigated to generate new 
25 insights into the osteoblast-PGF interaction. The underlying mechanisms established will provide 
26 useful hints for further bone tissue regeneration and PGF-based medical device development 
27 strategies. 
28 2. Materials and Methods
29 2.1 Materials fabrication
30 Phosphate glass fibers were produced using NaH2PO4, CaHPO4, FePO4·2H2O, and P2O5 as 
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1 raw materials (Sigma Aldrich, UK), as reported previously by Felfel et al31. Briefly, The 
2 precursors were weighed according to the nominal composition 50P2O5–40CaO5–5Na2O–5Fe2O3 
3 (in mol%) ——denoted as P50, and then melted in a Pt-Au crucible at 1100 ℃  for 90 min. 
4 Continuous fibers with a diameter in the range ~10-20 µm were then produced from the molten 
5 glass via an in-house melt-draw spinning facility at ~1600 rpm, followed by annealing at 5℃  
6 below the glass transition temperature (Tg=479℃) for 90 min. The as-prepared PGF bundles were 
7 chopped into short PGF meshes with the length of 2-3 mm before further utilization.
8 2.2 Morphology and calcium ion release measurements
9 Chopped PGFs were immersed in 75 vol% ethanol, subjected to ultrasonication treatment for 
10 20 min, and then dried in vacuum desiccator at 50℃ overnight. The samples were adhered onto a 
11 sample holder using conductive carbon tape and then sputter-coated with gold for 1.5 min. 
12 Scanning electron microscopy (SEM, TESCAN VEGA 3 SBH) and energy dispersive X-ray 
13 Spectrometer (EDX, Bruker Instruments, Germany) were used to evaluate the morphology and 
14 elemental composition of the produced PGFs. For calcium ion release test, 0.05 g of PGFs were 
15 added in a plastic bottle containing 30 ml PBS and placed inside an incubator at 37℃. After 3 h, 6 
16 h, 12 h, 24 h, 3 d, 7 d, 14 d and 21 d, 3 ml of the supernatant was extracted for measurement, and 
17 the bottle was refilled with another 3 ml of fresh PBS to maintain constant volume of release 
18 medium. The calcium concentration was measured by atomic absorption spectroscopy (ZEEnit 
19 700P, Analytik Jena AG, Germany). Three replicates were measured at each time point.
20 2.3 Cell culture
21 MC3T3-E1 cell line was purchased from ATCC (Manassas, USA) and cultured in α-MEM 
22 (Gibco, Carlsbad, USA) supplemented with 10% FBS (Biological Industries, Kibbutz 
23 BeitHaemek, Israel), 1% L-glutamine (Sigma–Aldrich, St. Louis, MO), 100 U/ml penicillin and 
24 100 μg/ml streptomycin. Osteogenesis of MC3T3-E1 cells was induced by condition medium in 
25 α-MEM (Gibco, Carlsbad, USA) supplemented with 10% FBS (Gibco, Carlsbad, USA), 100 
26 μg/ml streptomycin, 100 U/ml penicillin, 50 μg/ml ascorbicacid and 10 mM β–glycerophosphate 
27 (Sigma-Aldrich, MO, USA). The density of cells to be seeded was 6 × 105 cells per well of 
28 24-well plate. Cells were incubated at 37℃ using a 5% CO2 incubator.
29 2.4 Cell proliferation
30 For cell proliferation assay, MC3T3-E1 cells were seeded with different concentrations of 
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1 PGFs (0, 0.5 and 1 mg/ml) in 24-well plate. After culturing in condition medium for 0 d, 3 d and 5 
2 d respectively, the proliferation ability of the cells was analyzed by Cell Counting Kit-8 (CCK-8) 
3 (Beyotime Institution of Biotechnology, Jiangsu, China). Briefly, 300 μl of CCK-8 regent was 
4 added in each well and incubated for another 2 h at 37℃ . And then absorbance was detected at 
5 450 nm using microplate reader (Synergy HT, BioTek, USA). The results were expressed as the 
6 mean absorbance of four parallel tests.
7 2.5 Immunofluorescence assay
8 MC3T3-E1 cells were seeded with different concentrations of PGFs (0, 0.5 and 1 mg/ml). 
9 After the predetermined time point in condition medium, cells were washed 2-3 times with 
10 pre-cooled PBS, then the cells with materials were fixed with 4% paraformaldehyde for 15 min 
11 and washed again with pre-cooled PBS for 2-3 times. The cells were then permeabilized with 
12 0.5% Triton X-100 for 10 min and then washed again 2-3 times with pre-cooled PBS. After which 
13 the cells were then stained with 0.5 μg/ml Phalloidin-TRITC (sigma, USA), 4 μg/ml Vinculin and 
14 2 μg/ml Runx2 in dark overnight respectively. After incubation, cells were washed twice with 
15 pre-cooled PBS. Finally, the nuclei were stained with 1 μg/ml of DAPI 
16 (4,6-diamidino-2-phenylindole) in dark for 3 min, washed twice with pre-cooled PBS for 3-5 min. 
17 The protein expression was observed under fluorescence microscope (Nikon 80i, Japan). 
18 2.6 Alkaline phosphatase (ALP) activity assay
19 Cells were cultured with different concentrations of PGFs (0, 0.5 and 1 mg/ml) in 24-well 
20 plate with condition medium for 3, 7, 14 and 21 d, respectively. The ALP activity was analyzed by 
21 Alkaline Phosphatase Assay Kit (Beyotime Institution of Biotechnology, Jiangsu, China). Briefly, 
22 the samples were washed with PBS for 2-3 times and then lysed with 50 μl of 0.1% Triton X-100 
23 (Sigma-Aldrich, MO, USA) for 30 min at 4℃ . The lysate was centrifuged at 12000 rpm for 10 
24 min at 4℃. 20 μl of supernatant was added into chromogenic substrate and incubated for 10 min 
25 at 37℃. Then the reaction was discontinued by adding stop solution. Absorbance was detected at 
26 405 nm using microplate reader (Synergy HT, BioTek, USA). The results were expressed as the 
27 mean absorbance of three parallel tests.
28 2.7 Alizarin red S staining
29 Cells were cultured with different concentrations of PGFs (0, 0.5 and 1 mg/ml) in condition 
30 medium for 0, 3, 7, 14 and 21 d, respectively. Treated cells were fixed in 4% paraformaldehyde 
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1 for 10 min, and then washed with PBS for 2-3 times. Mineralized nodules were stained by 
2 incubating with 0.5% alizarin red (pH=4.2) (Sigma-Aldrich, MO, USA) for 15 min at room 
3 temperature. Then the excess stain was washed with double distilled water. The optical images of 
4 the stained nodules were observed by scanner (Cannon, Japan).
5 2.8 Real-Time RT-PCR
6 MC3T3-E1 cells cultured with different concentrations of PGFs (0, 0.5 and 1 mg/ml) in 
7 24-well plate for 3, 7, 14 and 21 d, respectively, and the expression of osteogenic marker genes 
8 and adhesion-related genes were detected by Real-time PCR method. Total RNAs were isolated 
9 from MC3T3-E1 cells by TRIzol reagent (Invitrogen, USA) according to the manufacturer’s 
10 instructions, and cDNA was synthesized using one-step PrimeScript RT reagent kit (TaKaRa, 
11 Dalian, China) for mRNA analysis. Real-Time PCR assay for mRNA analysis was performed by 
12 SYBR Premix Ex TaqIIkit (TaKaRa, Dalian, China). Real-Time RT-PCR was performed using 
13 Thermal Cycler C-1000 Touch system (Bio-Rad, Hercules, CA) and GAPDH was used as control 
14 for mRNA detection (n=3). Primers used for Real-Time PCR were listed in Table 1.
15 2.9 Statistical analysis
16 Data were expressed as mean±SD from independent experiments. Student’s two-tailed t-test 
17 was performed to determine the significance of differences. Values were considered statistically 
18 significant at **p<0.01 or *p<0.05.
19 3. Results
20 3.1 Material characterization
21 The morphology and elemental composition of the synthesized PGFs are showed in Figure 1. 
22 The SEM result showed that PGFs possessed smooth surface with a diameter of 12.48±0.19 μm 
23 (Figure 1A). Surface EDX analysis was also performed to measure the elemental composition of 
24 the produced PGFs. The EDX pattern of the selected area in Figure 1B revealed the presence of 
25 calcium, phosphorus, iron, sodium and oxygen, and the atomic composition of the detected 
26 elements as presented in the inset table is in agreement with the designed composition (P50). The 
27 release profiles of calcium ions from PGFs, which is closely associated with the formation of HA 
28 phase, are plotted in Figure 1C. A burst ion release up to 2.69 μg/mg was detected during the first 
29 day of incubation, then stable ion release with an additional release amount of 4.34 μg/mg was 
30 measured during the whole incubation period.
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1 3.2 Spreading of osteoblasts with PGFs 
2 The morphology of osteoblasts on different concentrations (0, 0.5 and 1 mg/ml) of PGFs in 
3 condition medium for 0, 3 and 5 days is shown in Figure 2A. Cells on culture plate with 0 mg/ml 
4 of PGFs were used as the control group. Compared with the control group, MC3T3-E1 cells 
5 spread well on PGFs. At the beginning of induction, MC3T3-E1 cells cultured without PGFs 
6 exhibited completely confluence. However, MC3T3-E1 cells were more inclined to spread 
7 towards PGFs with increasing concentrations. After culturing for 5 d, an increasing number of 
8 MC3T3-E1 cells was observed on and between the 1 mg/ml of PGF fibers (as indicated by the 
9 arrows in Figure 2A). 
10 The cytoskeleton of MC3T3-E1 cells on PGF fibers was performed by labeling the 
11 organization of F-actin stress fiber using immunofluorescence assay. The results showed that 
12 MC3T3-E1 cells on PGFs possessed wide spreading cellular actin filaments and polygonal cell 
13 shape, especially in the 1 mg/ml of PGF group (indicated by the arrows). Whilst the orientated 
14 cellular actin filaments and fibroblast-like osteoblasts were seen in the control group (Figure 2B). 
15 These results indicated that MC3T3-E1 cells preferred to spread on the PGF fibers with polygonal 
16 cell shape, probably due to the interlaced morphology of the PGF meshes and preferential 
17 adhesion of osteoblasts on the PGFs. 
18 3.3 Adhesion and proliferation of osteoblasts
19 MC3T3-E1 cells were seeded on PGFs and cultured in condition medium for 72 h. The 
20 adhesion of cells was investigated by double fluorescent labeling of vinculin protein, one of the 
21 focal adhesion complexes. Compared with the control group, cells were more prone to adhere onto 
22 the surface of the PGFs probably through vinculin (Figure 3A) (as indicated by the arrows). The 
23 mRNA expression level of adhesion-related genes including Vinculin, Fibronectin 1 and Collagen 
24 type Ⅲ alpha 1 (Col3α1) were selected for the RT-PCR study. The result showed that PGFs 
25 increased the expression of Vinculin and Fibronectin 1 significantly (Figure 3B). Therefore, it was 
26 concluded that PGFs induced adhesion of osteoblasts in the early osteogenesis stage. The 
27 proliferation of MC3T3-E1 cells cultured with the different concentrations of PGFs was assessed 
28 using CCK-8 assay. The result showed that 0.5 mg/ml and 1 mg/ml of PGFs significantly 
29 promoted the proliferation of MC3T3-E1 cells at day 3 and day 5 (Figure 3C). Hence, it is also 
30 suggested that the addition of PGFs, especially for the 1 mg/ml dose, played an important role in 
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1 the proliferation of MC3T3-E1 cells at the initial stages of osteogenesis. 
2 3.4 ALP activity and Alizarin red S staining of mineralized nodules
3 The alkaline phosphatase activity of osteoblasts cultured with different concentrations of 
4 PGFs was investigated. During the osteogenic differentiation, the ALP activity of MC3T3-E1 cells 
5 on culture plate reached the maximum after 14 days and then decreased by day 21. In contrast, the 
6 ALP activity continuously increased during the culture period with both 0.5 and 1 mg/ml of PGF. 
7 Moreover, compared with the control group, the MC3T3-E1 cells cultured with PGFs exhibited 
8 lower ALP activity at day 3 and day 7, but higher ALP activity at day 14 and day 21. In addition, 
9 ALP activity of cells on 1 mg/ml of PGFs was significantly higher than for cells on 0.5 mg/ml of 
10 PGFs at 14 and 21 days (Figure 4A). These results suggested that PGFs could promote osteoblast 
11 osteogenesis and delay the differentiation process by a concentration-dependent manner.
12 To confirm the effect of PGFs on osteogenic differentiation, alizarin red staining was 
13 performed to detect the possible mineral deposits on cell surfaces during osteogenic induction 
14 after 0, 3, 7, 14 and 21 days (Figure 4B). The scanning images showed that more mineral 
15 deposition was observed on the cells cultured with 0.5 mg/ml and 1 mg/ml of PGF and no mineral 
16 formed in PGFs without cells (Figure S1). These data indicate that the PGFs could promote the 
17 osteogenic differentiation of MC3T3-E1 cells.
18 3.5 mRNA expression of osteogenic differentiation markers
19 In order to evaluate the effect of PGFs on osteoblast differentiation during osteogenesis, the 
20 mRNA expression level of osteogenesis-related marker genes including ALP, Osteocalcin (OCN), 
21 Osterix (Sp7), and Collagen type I alpha 1 (Col1α1) were selected for Real-time PCR study. 
22 MC3T3-E1 cells were cultured in osteogenic induction medium for 3, 7, 14 and 21 days. 
23 Compared with MC3T3-E1 cells on culture plate (0 mg/ml of PGF), all of these mRNAs were 
24 upregulated after 21 days of osteogenic induction on PGFs, and exhibited higher expression with 
25 increasing concentration of PGFs (Figure 5). At the induction of day 3 and day 7, the expression 
26 of early stage genes ALP and Sp7 in the PGF group was lower compared to the control group, 
27 such delayed expression may have been due to the increased proliferation of cells on PGFs at the 
28 beginning of osteogenesis. 
29 3.6 Wnt/β-catenin/Runx2 pathway analysis
30 In order to further investigate the effects of PGFs on osteoblast differentiation, downstream 
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1 genes of Wnt signaling pathway including β-catenin and Runt-related transcription factor 2 
2 (Runx2) were also detected by Real-time PCR assay. Runx2, which is regulated by β-catenin in 
3 Wnt signaling pathway, is an important transcription factor for osteoclast generation. Two target 
4 genes of β-catenin, Axin2 and c-myc, were regarded as positive control. The results showed that 
5 PGFs upregulated β-catenin after 7 days of induction. The expression of Runx2, Axin2 and c-myc 
6 were also significantly upregulated in the PGF group at 21 days (Figure 6A). 
7 MC3T3-E1 cells were cultured on PGFs in osteogenic induction medium for 21 days and the 
8 impact of PGFs on the protein expression of Runx2 was then examined by immunofluorescence 
9 assay. The results showed that the protein expression of Runx2 was upregulated in the cells 
10 cultured with PGFs (Figure 6B). Thus, we suggest that PGFs could promote osteogenic 
11 differentiation by upregulating Runx2 expression through Wnt/β-catenin signal pathway. 
12 4. Discussion
13 As a bioactive material for bone tissue engineering, phosphate glass fibers (PGFs) have been 
14 found to be biocompatible and osteo-conductive to bone-related cells, such as osteoblasts and 
15 bone marrow derived MSCs11, 32. The P50 PGFs possess the ability of releasing calcium ions in a 
16 sustained released manner, which would be highly beneficial for cell attachment and 
17 differentiation12, 19. In addition, the present study demonstrated that P50 PGFs of ~10 μm diameter 
18 with interlaced oriented topography significantly increased osteoblast adhesion, spreading, 
19 proliferation and differentiation during osteogenesis. The most important factor observed was that 
20 the PGFs investigated promoted osteogenic differentiation, indicated by the up-regulated 
21 expression of osteogenic marker genes, increased ALP activity and extracellular matrix 
22 mineralization, as suggested through Wnt/β-catenin signal pathway by regulating transcription 
23 factor Runx2. Therefore, for the development of synthetic orthopaedic devices based on PGFs, the 
24 design of fiber orientation and the release of therapeutic ions would be very highly beneficial. 
25 It is well known that the topography of biomaterials can have significant influence on 
26 regulating cell behavior such as cell attachment, spreading and proliferation33-35. Yiping Li et al. 
27 reported that increased cell spreading area of randomly oriented fibrous scaffolds promoted the 
28 spreading of MSCs with more filopodia36. As demonstrated in this study, osteoblasts cultured on 
29 the interlaced PGF meshes were more inclined to spread among the PGFs with increasing 
30 concentrations. Compared with cells on culture plate with orientated cellular actin filaments and 
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1 fibroblast-like shape, F-actin of MC3T3-E1 cells on PGFs showed wide spreading of cellular actin 
2 filaments with polygonal cell shape (Figure 2). The cytoskeletal F-actin arrangement can also 
3 further influence osteoblast differentiation and function37. Focal adhesions emerged as diverse 
4 protein complexes that provide a dynamic link of the intracellular actin cytoskeletons to an 
5 extracellular matrix (ECM)38. Vinculin indicates the locations of focal adhesions39. Compared to 
6 the control group, osteoblasts spread well on PGFs and the cytoskeleton displayed a better shape 
7 that allowed the cells to be more prone to adhere on PGF surfaces tightly through higher expressed 
8 vinculin (Figure 3A). Furthermore, the mRNA expression of adhesion-related genes including 
9 Vinculin and Fibronectin 1 was increased significantly in PGF groups (Figure 3B). These 
10 experimental results demonstrate that topography of PGFs could be optimized to improve cell 
11 adhesion and spreading with more filopodia in the early osteogenesis stage. Furthermore, due to 
12 the increased aspect ratio in the presence of PGFs, MC3T3-E1 cells cultured with PGFs 
13 proliferated at a significantly faster rate than those cultured on pure culture plate alone at the early 
14 stage of osteogenesis (Figure 3C). The PGFs investigated not only enhanced the initial adhesion, 
15 but also promoted the proliferation of osteoblasts, indicating that these PGFs displayed superior 
16 biocompatibility by providing a stable surface for a more suitable interface for the growth of 
17 osteoblasts in vitro. 
18 Apart from the surface topography of substrates, the effect of surface properties is also an 
19 important factor that contributes to osteogenic response40. Calcium ion release has been reported 
20 to be able to accelerate osteoblast differentiation with increased secretion of bone-associated 
21 components in vitro and to enhance osseointegration in vivo41-44. In our study, the EDX analysis 
22 combined with calcium ion release assay confirmed the presence of calcium within the PGFs 
23 investigated and the Ca ion release profile for this P50 formulation (Figure 1B, C). Furthermore, 
24 osteoblasts cultured with the P50 PGFs showed significantly increased ALP activity at 21 days of 
25 osteogenic induction (Figure 4A) and the extracellular matrix mineralization assay result also 
26 showed similar trends (Figure 4B). In osteogenesis, ALP activity is an important early marker and 
27 mineralized nodules are a later marker for cells undergoing differentiation into mature 
28 osteoblasts20. In addition, differentiation is also verified by assessing the induction of specific 
29 genes45. Osteoblastic markers ALP, Col I, Sp7 and OCN were also up-regulated in cells cultured 
30 with PGFs, and revealed more obvious changes in the later differentiation (Figure 5). Therefore, 
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1 calcium ion release probably acts as a major factor that contributed to osteogenic differentiation 
2 from the PGFs. It was also noticed that mRNA expression and activity of ALP of osteoblasts in 
3 PGF groups both decreased after days 3 and 7 of induction compared to the control. This 
4 inhibition effect of cell differentiation in the presence of PGFs could possibly be related to the 
5 proliferation tendency of MC3T3-E1 cells in the early stage, due to the reciprocal relationship 
6 between cell proliferation and differentiation19, 46. In our ongoing research, we also focus on the 
7 function of PGFs with different constituents and topography on osteoblast behavior. 
8 It has been reported that calcium ion induced Wnt signaling is essential for bone tissue 
9 formation25-27. Previous studies have shown that Wnt/β-catenin/Runx2 axis stimulates osteoblast 
10 activation and subsequently leads to bone formation47, 48. As a main regulator, Runx2 can regulate 
11 the expression of downstream key genes, such as Col I, ALP, and OCN at the early stage of 
12 osteoblastic differentiation and the later key transcription factor Osterix49, 50. In the present study, 
13 real-time PCR determined that the level of β-catenin and Runx2 were significantly increased in the 
14 PGF groups (Figure 6). Immunofluorescence staining of Runx2 protein also showed greater 
15 expression in PGF groups compared to that of the control. Our results demonstrated that the 
16 mechanism of P50 PGFs on promoting osteogenesis is related to the fact that 
17 Wnt/β-catenin/Runx2 signaling pathway participates in osteogenic differentiation of osteoblasts. 
18 These results provided thus useful insight and suggest great potential of P50 PGFs for application 
19 in bone tissue engineering.
20 5. Conclusions
21 This study investigated P50 PGFs and the osteogenic mechanism that result from the 
22 interaction of osteoblasts with difference concentrations of interlaced oriented PGFs. The results 
23 demonstrated that topographical structure and bioactive ion release of P50 PGFs influence the 
24 upregulation of osteogenic marker genes, ALP activity and extracellular matrix mineralization. 
25 The P50 PGFs investigated promoted osteogenic differentiation of osteoblasts by regulating 
26 Runx2 through Wnt/β-catenin signaling pathway. Taken together, the results indicate that P50 
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1 Figure Legends
2 Figure 1. (A) SEM micrographs of PGFs. (B) the corresponding EDAX spectrum of PGFs. (C) 
3 the concentration of released calcium ion from PGFs in PBS (pH=7.4) for 3 h, 6 h, 12 h, 24 h, 3 d, 
4 7 d, 14 d and 21 d.
5 Figure 2. (A) the morphology of MC3T3-E1 cells cultured with different concentrations of 
6 interlaced oriented PGFs for 0 d, 3 d and 5 d, respectively. Scale bar: 100 μm. (B) F-actin staining 
7 of cells with different concentrations of PGFs for 5 d in condition medium. Scale bar: 50 μm. The 
8 arrows indicated the cells with multidirectional outspread.
9 Figure 3. (A) the staining of focal adhesion protein vinculin in MC3T3-E1 cells cultured with 
10 different concentrations of PGFs for 3 days of induction. The arrows indicated the MC3T3-E1 
11 cells with better adhesion on and among the substrates. Scale bar: 50 μm. (B) MC3T3-E1 cells 
12 cultured with different concentrations of PGFs for 3 d, the expression of adhesion-related genes 
13 including Vinculin, Fibronectin 1 and Collagen type Ⅲ  alpha 1 (Col3α1) were measured by 
14 Real-time PCR. (C) the proliferation of MC3T3-E1 cells cultured with different concentrations of 
15 PGFs for 0 d, 3 d and 5 d were measured by CCK-8 assay. Data are presented as the average ± 
16 SD. *p<0.05 and **p<0.01 versus control group.
17 Figure 4. (A) ALP activity of MC3T3-E1 cells cultured with different concentrations of PGFs for 
18 3 d, 7 d, 14 d and 21 d in condition medium respectively. (B) Alizarin red staining of MC3T3-E1 
19 cells with different concentrations of PGF for 0 d, 3 d, 7 d, 14 d and 21 d, respectively. Data are 
20 presented as the average ± SD. *p<0.05 and **p<0.01 versus control group.
21 Figure 5. (A-D) MC3T3-E1 cells cultured with different concentrations of PGFs for 3 d, 7 d, 14 d 
22 and 21 d, respectively. The expression of osteogenic-related genes including ALP (A), OCN (B), 
23 Sp7 (C), and Col1α1 (D) were measured by Real-time PCR. Data are presented as the average ± 
24 SD. *p<0.05 and **p<0.01 versus control group.
25 Figure 6. (A) MC3T3-E1 cells cultured with different concentrations of PGFs for 3 d, 7 d, 14 d 
26 and 21 d, respectively. The expression of β-catenin and downstream genes Runx2, Axin2 and 
27 c-myc were measured by Real-time PCR. (B) Immunofluorescence assay of Runx2 protein 
28 expression was measured in MC3T3-E1 cells with different concentrations of PGFs for 21 d in 
29 condition medium. Scale bar: 50 μm. Data are presented as the average ± SD. *p<0.05 and 
30 **p<0.01 versus control group.
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Graphical abstract: Illustration of the synergistic effects of topographical structure and released calcium ion 
of interlaced PGF scaffolds on osteoblast behaviors. 
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Figure 1. (A) SEM micrographs of PGFs. (B) the corresponding EDAX spectrum of PGFs. (C) the 
concentration of released calcium ion from PGFs in PBS (pH=7.4) for 3 h, 6 h, 12 h, 24 h, 3 d, 7 d, 14 d and 
21 d. 
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Figure 2. (A) the morphology of MC3T3-E1 cells cultured with different concentrations of interlaced oriented 
PGFs for 0 d, 3 d and 5 d, respectively. Scale bar: 100 μm. (B) F-actin staining of cells with different 
concentrations of PGFs for 5 d in condition medium. Scale bar: 50 μm. The arrows indicated the cells with 
multidirectional outspread. 
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Figure 3. (A) the staining of focal adhesion protein vinculin in MC3T3-E1 cells cultured with different 
concentrations of PGFs for 3 days of induction. The arrows indicated the MC3T3-E1 cells with better 
adhesion on and among the substrates. Scale bar: 50 μm. (B) MC3T3-E1 cells cultured with different 
concentrations of PGFs for 3 d, the expression of adhesion-related genes including Vinculin, Fibronectin 1 
and Collagen type Ⅲ alpha 1 (Col3α1) were measured by Real-time PCR. (C) the proliferation of MC3T3-E1 
cells cultured with different concentrations of PGFs for 0 d, 3 d and 5 d were measured by CCK-8 assay. 
Data are presented as the average ± SD. *p<0.05 and **p<0.01 versus control group. 
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Figure 4. (A) ALP activity of MC3T3-E1 cells cultured with different concentrations of PGFs for 3 d, 7 d, 14 d 
and 21 d in condition medium respectively. (B) Alizarin red staining of MC3T3-E1 cells with different 
concentrations of PGF for 0 d, 3 d, 7 d, 14 d and 21 d, respectively. Data are presented as the average ± 
SD. *p<0.05 and **p<0.01 versus control group. 
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Figure 5. (A-D) MC3T3-E1 cells cultured with different concentrations of PGFs for 3 d, 7 d, 14 d and 21 d, 
respectively. The expression of osteogenic-related genes including ALP (A), OCN (B), Sp7 (C), and Col1α1 
(D) were measured by Real-time PCR. Data are presented as the average ± SD. *p<0.05 and **p<0.01 
versus control group. 
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Figure 6. (A) MC3T3-E1 cells cultured with different concentrations of PGFs for 3 d, 7 d, 14 d and 21 d, 
respectively. The expression of β-catenin and downstream genes Runx2, Axin2 and c-myc were measured 
by Real-time PCR. (B) Immunofluorescence assay of Runx2 protein expression was measured in MC3T3-E1 
cells with different concentrations of PGFs for 21 d in condition medium. Scale bar: 50 μm. Data are 
presented as the average ± SD. *p<0.05 and **p<0.01 versus control group. 
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Table 1. Primer sequences used in Real-Time RT-PCR











Fibronectin 1 GCGACTCTGACTGGCCTTAC CCGTGTAAGGGTCAAAGCAT
Col3α1 GTCCACGAGGTGACAAAGGT CATCTTTTCCAGGAGGTCCA
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